Matrix Metalloprotease Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 2622 | ARP 101 |
| Inhibitor of MMP-2 | |
| 2961 | Batimastat |
| Potent, broad spectrum MMP inhibitor | |
| 2632 | CL 82198 hydrochloride |
| Selective inhibitor of MMP-13 | |
| 4090 | Doxycycline hyclate |
| Broad-spectrum MMP inhibitor; tetracycline derivative | |
| 2983 | GM 6001 |
| Broad spectrum MMP inhibitor | |
| 7030 | GW 280264X |
| Potent ADAM10 and ADAM17 endopeptidase nhibitor | |
| 6439 | JNJ 0966 |
| Pro-MMP9 activation inhibitor | |
| 2631 | Marimastat |
| Broad spectrum MMP inhibitor | |
| 3268 | Minocycline hydrochloride |
| Inhibitor of MMP activity | |
| 4902 | NSC 405020 |
| Inhibitor of MT1-MMP; antitumor | |
| 2520 | PD 166793 |
| Broad spectrum MMP inhibitor | |
| 6088 | SB 3CT |
| High affinity and selective MMP2 inhibitor | |
| 4775 | SD 2590 hydrochloride |
| Potent MMP inhibitor | |
| 6134 | T 26c disodium salt |
| Highly potent and selective MMP13 inhibitor | |
| 5523 | TAPI 0 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 6162 | TAPI 1 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 6013 | TAPI 2 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 2900 | UK 370106 |
| Highly selective MMP-3 and MMP-12 inhibitor | |
| 4188 | UK 383367 |
| Potent and selective BMP-1 (PCP) inhibitor | |
| 2633 | WAY 170523 |
| Potent and selective inhibitor of MMP-13 |
Cancer Research Product Guide
Our Cancer Research Guide highlights over 750 products for cancer research.
Request copyRequest PDFAngiogenesis in Cancer Life Science Poster
Taken from the Cancer Product Guide Edition 3
Our Angiogenesis in Cancer poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.
Request copyDownload PDF